Scholars@Duke publication: Correction:<i>Characterization of tumor mutation burden, PD-L1 and DNA repair genes to assess relationship to immune checkpoint inhibitors response in metastatic renal cell carcinoma</i>

Correction:Characterization of tumor mutation burden, PD-L1 and DNA repair genes to assess relationship to immune checkpoint inhibitors response in metastatic renal cell carcinoma

Publication , Journal Article

Published in: Journal for ImmunoTherapy of Cancer

May 2020

Published version (DOI) Publisher Link

Duke Scholars

Author Matthew Kyle Labriola Medicine, Medical Oncology

Author Rajan Tilak Gupta Radiology, Abdominal Imaging

Published In

Journal for ImmunoTherapy of Cancer

DOI

10.1136/jitc-2019-000319corr1

EISSN

2051-1426

Publication Date

May 2020

Volume

Issue

Start / End Page

e000319corr1 / e000319corr1

Publisher

BMJ

Related Subject Headings

3211 Oncology and carcinogenesis
3204 Immunology

Citation

APA

Chicago

ICMJE

MLA

NLM

Correction:Characterization of tumor mutation burden, PD-L1 and DNA repair genes to assess relationship to immune checkpoint inhibitors response in metastatic renal cell carcinoma. (2020). Journal for ImmunoTherapy of Cancer, 8(1), e000319corr1-e000319corr1. https://doi.org/10.1136/jitc-2019-000319corr1

“Correction:Characterization of tumor mutation burden, PD-L1 and DNA repair genes to assess relationship to immune checkpoint inhibitors response in metastatic renal cell carcinoma.” Journal for ImmunoTherapy of Cancer 8, no. 1 (May 2020): e000319corr1-e000319corr1. https://doi.org/10.1136/jitc-2019-000319corr1.

Correction:Characterization of tumor mutation burden, PD-L1 and DNA repair genes to assess relationship to immune checkpoint inhibitors response in metastatic renal cell carcinoma. Journal for ImmunoTherapy of Cancer. 2020 May;8(1):e000319corr1-e000319corr1.

“Correction:Characterization of tumor mutation burden, PD-L1 and DNA repair genes to assess relationship to immune checkpoint inhibitors response in metastatic renal cell carcinoma.” Journal for ImmunoTherapy of Cancer, vol. 8, no. 1, BMJ, May 2020, p. e000319corr1-e000319corr1. Crossref, doi:10.1136/jitc-2019-000319corr1.

Correction:Characterization of tumor mutation burden, PD-L1 and DNA repair genes to assess relationship to immune checkpoint inhibitors response in metastatic renal cell carcinoma. Journal for ImmunoTherapy of Cancer. BMJ; 2020 May;8(1):e000319corr1-e000319corr1.

Published In

Journal for ImmunoTherapy of Cancer

DOI

10.1136/jitc-2019-000319corr1

EISSN

2051-1426

Publication Date

May 2020

Volume

Issue

Start / End Page

e000319corr1 / e000319corr1

Publisher

BMJ

Related Subject Headings

3211 Oncology and carcinogenesis
3204 Immunology